Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy. [electronic resource]
Producer: 20040420Description: 1273-86 p. digitalISSN:- 0022-1767
- Animals
- Cell Differentiation -- drug effects
- Cell Line
- Cell Migration Inhibition
- Cell Movement -- drug effects
- DNA-Binding Proteins -- biosynthesis
- Encephalomyelitis, Autoimmune, Experimental -- enzymology
- Epitopes, T-Lymphocyte -- immunology
- Female
- GATA3 Transcription Factor
- Growth Inhibitors -- pharmacology
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- administration & dosage
- Injections, Intraperitoneal
- Interphase -- drug effects
- Lovastatin -- administration & dosage
- Mice
- Mice, Inbred Strains
- Multiple Sclerosis -- drug therapy
- Myelin Proteolipid Protein -- antagonists & inhibitors
- Neurons -- drug effects
- Spinal Cord -- drug effects
- T-Box Domain Proteins
- T-Lymphocyte Subsets -- drug effects
- Th1 Cells -- drug effects
- Th2 Cells -- drug effects
- Trans-Activators -- biosynthesis
- Transcription Factors -- antagonists & inhibitors
- Up-Regulation -- drug effects
- T-bet Transcription Factor
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.